Efficacy of FLUTIFORM ® vs Seretide® in Moderate to Severe Persistent Asthma in Subjects Aged ≥12 Years
Clinical trial NCT03387241 · UNKNOWN
Trial details
- NCT number
- NCT03387241
- Sponsor
- Mundipharma (China) Pharmaceutical Co. Ltd
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-02
- Primary completion
- 2019-12-30
- Enrollment
- 330
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.